Additionally, our data link the RNA binding proteins CUG-BP1 and MBNL1 with IR alternative splicing and this interplay between the two could further be exploited in therapeutic and mechanistic directions for other cancers and diseases for which insulin signaling is affected. The gene discussed is CELF1; the disease is cancer.